Imidazolecarboxamides and Their Use as FAAH Inhibitors
申请人:BIAL - PORTELA & Cª, S.A.
公开号:US20160176854A1
公开(公告)日:2016-06-23
A compound having a structure selected from the following:
or a pharmaceutically acceptable salt thereof. The compound may be used as an inhibitor of fatty acid amide hydrolase.
具有以下结构之一的化合物或其药学上可接受的盐。该化合物可用作脂肪酸酰胺水解酶的抑制剂。
IMIDAZOLECARBOXAMIDES AND THEIR USE AS FAAH INHIBITORS
申请人:Bial-Portela & CA, S.A.
公开号:EP3024825A1
公开(公告)日:2016-06-01
[EN] IMIDAZOLECARBOXAMIDES AND THEIR USE AS FAAH INHIBITORS<br/>[FR] IMIDAZOLECARBOXAMIDES ET LEUR UTILISATION COMME INHIBITEURS DE FAAH
申请人:BIAL PORTELA & Cª S A
公开号:WO2015012708A1
公开(公告)日:2015-01-29
A compound having a structure selected from the following: or a pharmaceutically acceptable salt thereof. The compound may be used as an inhibitor of fatty acid amide hydrolase.